CAFs-induced ECM remodeling results in increased tissue stiffness and the activation of mechanotransduction signaling pathways, such as integrin-FAK and YAP/TAZ signaling, thereby conferring increased malignancy to tumors (121)
Gordon recognized the association between TBI, hormonal imbalances and neurobehavioral conditions
The ultimate in performance enhancement plus a metabolism kick to get you going
In February 2026, HHS Secretary Kennedy announced the expected reclassification of approximately 14 Category 2 peptides including GHK-Cu to Category 1, which would enable prescription compounding, though formal FDA rulemaking had not yet been completed at that time [1]
Endocrinology (1999) Raun K, Hansen BS, Johansen NL, et al